Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Fletcher

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|November 23, 2000
Indinavir plasma protein binding in HIV-1-infected adultsP L Anderson, R C Brundage, L Bushman, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDSC V Fletcher, B K Goodroad, L M Cummins, et al.
JAMA|May 27, 1988
Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complexK Henry, B J Chinnock, R P Quinn, et al.
Antimicrobial Agents and Chemotherapy|May 11, 1991
Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipientsC V Fletcher, J A Englund, C K Edelman, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1988
Ganciclovir pharmacokinetics during renal impairmentK D Lake, C V Fletcher, K R Love, et al.
Clinical Pharmacology and Therapeutics|July 5, 2007
Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trialC V Fletcher, R C Brundage, T Fenton, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapyC V Fletcher, R C Brundage, R P Remmel, et al.
AIDS (London, England)|November 4, 2000
Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected personsC V Fletcher, S P Kawle, T N Kakuda, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1994
Foscarnet for suppression of human immunodeficiency virus replicationC V Fletcher, A C Collier, F S Rhame, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|November 23, 2000
Indinavir plasma protein binding in HIV-1-infected adultsP L Anderson, R C Brundage, L Bushman, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDSC V Fletcher, B K Goodroad, L M Cummins, et al.
JAMA|May 27, 1988
Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complexK Henry, B J Chinnock, R P Quinn, et al.
Antimicrobial Agents and Chemotherapy|May 11, 1991
Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipientsC V Fletcher, J A Englund, C K Edelman, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1988
Ganciclovir pharmacokinetics during renal impairmentK D Lake, C V Fletcher, K R Love, et al.
Clinical Pharmacology and Therapeutics|July 5, 2007
Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trialC V Fletcher, R C Brundage, T Fenton, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapyC V Fletcher, R C Brundage, R P Remmel, et al.
AIDS (London, England)|November 4, 2000
Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected personsC V Fletcher, S P Kawle, T N Kakuda, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1994
Foscarnet for suppression of human immunodeficiency virus replicationC V Fletcher, A C Collier, F S Rhame, et al.
Pageof 7